# Study of APVO436 in Patients With AML or MDS

> **NCT03647800** · PHASE1 · UNKNOWN · sponsor: **Aptevo Research and Development LLC** · enrollment: 136 (estimated)

## Conditions studied

- AML
- MDS

## Interventions

- **BIOLOGICAL:** APVO436

## Key facts

- **NCT ID:** NCT03647800
- **Lead sponsor:** Aptevo Research and Development LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-13
- **Primary completion:** 2022-12-15
- **Final completion:** 2023-06-15
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2022-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03647800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03647800, "Study of APVO436 in Patients With AML or MDS". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03647800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*